Bullfrog AI Holdings, Inc. Common Stock (BFRG : NASDAQ)
Common Stock
$0.95
USD
+0.35 (58.33%)
Last updated: 2026-09-23
Follow BFRG
BFRG
Bullfrog AI Holdings, Inc. Common Stock
Performance
1 Day
+58.33%
1 Week
+121.70%
1 Month
+68.98%
YTD
+36.20%
Key Statistics
Market Cap
$17.61M
52W High
$2.04
52W Low
$0.43
P/E Ratio
-
50 Day MA
$0.56
200 Day MA
$0.71
Beta
-2.72
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/23/2026 | $0.78 | $1.05 | $0.70 | $0.95 | $0.95 | 191,727,176 |
| 9/22/2026 | $0.53 | $0.82 | $0.44 | $0.60 | $0.60 | 68,647,320 |
| 9/21/2026 | $0.47 | $0.50 | $0.47 | $0.49 | $0.49 | 218,168 |
| 9/18/2026 | $0.45 | $0.47 | $0.44 | $0.46 | $0.46 | 69,055 |
| 9/17/2026 | $0.43 | $0.47 | $0.43 | $0.47 | $0.47 | 175,805 |
| 9/16/2026 | $0.44 | $0.44 | $0.43 | $0.43 | $0.43 | 94,726 |
| 9/15/2026 | $0.48 | $0.48 | $0.44 | $0.45 | $0.45 | 87,128 |
| 9/14/2026 | $0.47 | $0.49 | $0.47 | $0.47 | $0.47 | 87,992 |
| 9/11/2026 | $0.48 | $0.50 | $0.46 | $0.48 | $0.48 | 65,900 |
| 9/10/2026 | $0.48 | $0.51 | $0.47 | $0.49 | $0.49 | 138,399 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BFRG's historical volatility
30-Day Vol
158.6%
Annualized
90-Day Vol
117.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$1.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.01 | US$0.58 – US$1.74 |
| 60 trading days | US$1.07 | US$0.49 – US$2.32 |
| 90 trading days | US$1.14 | US$0.44 – US$2.93 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bullfrog AI Holdings, Inc. Common Stock
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Financials
- Revenue (TTM)
- $298,798
- EBITDA
- $-6.10M
- Profit Margin
- 0.00%
- ROE (TTM)
- -130.71%
- EPS (Diluted)
- -0.72
- Book Value
- 0.38
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About BFRG.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BENF | Beneficient Class A Common Stock | $2.90 | +438.73% |
| JAGX | Jaguar Animal Health Inc | $8.91 | +233.71% |
| WHLR | Wheeler Real Estate Investment Trust, Inc. | $5.44 | +190.91% |
| VSA | TCTM Kids IT Education Inc. | $3.64 | +83.84% |
| ARTL | Artelo Biosciences Inc | $7.31 | +76.14% |
| VTGN | VistaGen Therapeutics Inc | $0.37 | +46.54% |
| IPDN | Professional Diversity Network Inc | $5.42 | +38.97% |
| ONCO | Onconetix Inc | $0.91 | +38.93% |